期刊文献+

阿尔茨海默病患者血清与脑脊液中多种细胞因子的研究 被引量:6

Research on the levels of TNF-α,IL-1β and IL-8 in serum and CSF of patients with Alzheimer's disease
下载PDF
导出
摘要 目的 探讨阿尔茨海默病(Alzheimer’sdisease ,AD)病因及发病机制。方法 采用双抗体夹心酶联免疫吸附试验分别对5 7例患者分为AD组和VaD组进行血清和脑脊液(CSF)肿瘤坏死因子-α(TNF- α)、白细胞介素- 1β(IL- 1β)及白细胞介素- 8(I-L 8)水平检测。对照组2 8例均无神经系统、免疫系统等疾病。结果 (1)AD组CSF中TNF- α水平明显高于VaD组和对照组,差异有显著性意义(P <0 .0 5 ,P <0 .0 1) ;(2 )AD组和VaD组CSF中IL- 1β水平明显高于对照组(P <0 .0 5 ) ,AD组血清中IL -1β水平明显高于VaD组和对照组,差异有显著性意义(P <0 .0 1) ;(3)AD组和VaD组血清和CSF中IL 8均明显高于对照组,差异显著(P <0 .0 5 ,P <0 .0 1) ;(4)AD组患者CSF中的TNF -α、IL -1β及IL -8水平之间呈正相关(r =0 .0 6 ,P <0 .0 5 ) ;(5 )血清或CSF中的TNF- α、IL- 1β及IL -8检测水平与简易智力状态检查表(MMSE)得分之间均无相关性。结论 细胞因子可能参与了AD的病理生理过程。 Objective To investigate the etiology and pathogenesis of Alzheimer's disease (AD). Methods The levels of TNF-α, IL-1β and IL-8 in serum and cerebrospinal fluid ( CSF)of patients with AD were examined respectively by double antibody enzyme linked immunosorbent assay (ELISA). Results (1)The TNF-α level in CSF in AD group was significantly higher than that in VD(vascular dementia) and healthy control groups,with significant difference ( P 〈 0.05 or P 〈 0.01) ; (2)The level of IL-1β in CSF in AD and VD groups was significantly higher than that in the healthy control group, with significant difference ( P 〈 0.05). The level of IL-1β in serum in AD was significantly higher than that in VD and healthy control groups, with significant difference ( P 〈 0.01 ). (3) The levels of IL-8 in serum and CSF in AD and VD groups were significantly higher than those in the healthy control group,with significant difference ( P 〈 0.05 or P 〈 0.01); (4) A positive correlation existed between the levels of TNF-α, IL-1β and IL-8 in CSF of AD group ( r = 0.06, P 〈 0.05);(5) The levels of TNF-α, IL-1β and IL-8 in serum or CSF were not correlated with MMSE scores in AD group.Conclusion Measurement of cytokines(CK) may provide theoretical grounds for further shedding light on the CK function in AD pathogenesis, and helps to the diagnosis of AD and early protection from AD.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2005年第2期112-114,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 阿尔茨海默病 血清学 脑脊髓液 白细胞介素类 细胞因子类 Alzheimer disease serology cerebrospinal fluid interleukins cytokines
  • 相关文献

参考文献2

二级参考文献35

  • 1Bergamaschini L,Canziani S,Bottasso B,et al.Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner[J].Clin Exp Immunol,1999,115(3):526-533.
  • 2Mrak RE,Griffin WS.Interleukin-1,neuroinflammation,and Alzheimer's disease[J].Neurobiol Aging,2001,22(6):903-908.
  • 3Terreni L,De Simoni MG.Role of the brain in interleukin-6 modulation[J].Neuroimmunomodulation,1998,5(3-4):214-219.
  • 4Solomon Beka,Frenker Dan.Vaccination for the prevention and treatment of Alzheimer's disease[J].Drugs Today,2000,36(9):655-663.
  • 5DeWitt DA,Perry G,Cohen M,et al.Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease[J].Exp Neurol,1998,149(2):329-340.
  • 6Rogers J,Lue LF.Microglial chemotaxis,activation,and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease[J].Neurochem Int,2001,39(5-6):333-340.
  • 7Kalaria RN.Microglia and Alzheimer's disease[J].Curr Opin Hematol,1999,6(1):15-24.
  • 8Saas P,Boucraut J,Quiquerez AL,et al.CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation?[J].J Immunol,1999,162(4):2326-2333.
  • 9Strohmeyer R,Shen Y,Rogers J.Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain[J].Hum Mol Genet,2000,9(15):2281-2279.
  • 10Webster S,Bonnell B,Rogers J.Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide[J].Am J Pathol,1997,150(5):1531-1536.

共引文献28

同被引文献114

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部